HIGHLIGHTS
- who: Miguel A. Villalona-Calero from the City of Hope National Medical Center, Duarte, California, USA have published the research work: Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors, in the Journal: (JOURNAL)
- what: The results of our study are encouraging.
- how: The authors conducted a logistic regression analysis to find the association between FATSI status and iORR with adjustment for possible confounders such as age sex race and number of prior treatment regimens.
- future: Association to clinical endpoints was documented (but no formal statistics assessed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.